Recent JAN News
- JanOne Regains Compliance with Nasdaq's Listing Requirements • PR Newswire (US) • 03/15/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:22:34 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/09/2024 05:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:28:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:33:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/22/2023 09:00:42 PM
- JanOne to Present at the Dawson James 8th Annual Investment Conference • PR Newswire (US) • 09/21/2023 03:30:00 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:33:01 PM
- JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference • PR Newswire (US) • 08/31/2023 05:30:00 PM
- JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain • PR Newswire (US) • 08/29/2023 05:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2023 09:20:13 PM
- JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/25/2023 06:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 08/24/2023 08:30:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:33:11 PM
- JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/22/2023 09:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/22/2023 04:54:17 PM
- JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/18/2023 11:00:00 PM
- JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/18/2023 04:42:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/16/2023 07:55:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 08:39:17 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/07/2023 08:19:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 08:24:10 PM
- JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain • PR Newswire (US) • 06/28/2023 12:30:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM